NEW YORK (Reuters) - It may take a breakthrough treatment for Alzheimer's disease to match the $130 billion lifetime sales record of Pfizer's Lipitor, the cholesterol fighter that wrote its own chapter in pharmaceutical history.
Lipitor's U.S. patent expires on November 30, unleashing a wave of cheap generics and ending a fabled run that began in 1997.
Join our Telegram channel to get our Evening Alerts and breaking news highlights
